1. Home
  2. GEVO vs ABSI Comparison

GEVO vs ABSI Comparison

Compare GEVO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gevo Inc.

GEVO

Gevo Inc.

N/A

Current Price

$1.56

Market Cap

340.8M

Sector

Industrials

ML Signal

N/A

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$8.23

Market Cap

997.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEVO
ABSI
Founded
2005
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.8M
997.8M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
GEVO
ABSI
Price
$1.56
$8.23
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$6.58
$6.96
AVG Volume (30 Days)
2.1M
2.7M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.82
10.64
EPS
N/A
N/A
Revenue
$711,000.00
$4,534,000.00
Revenue This Year
$19.44
$215.96
Revenue Next Year
$5.59
$319.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.37
$2.24
52 Week High
$2.97
$12.06

Technical Indicators

Market Signals
Indicator
GEVO
ABSI
Relative Strength Index (RSI) 47.43 40.77
Support Level $1.42 $6.69
Resistance Level $1.73 $10.03
Average True Range (ATR) 0.08 0.54
MACD -0.01 -0.12
Stochastic Oscillator 30.77 0.81

Price Performance

Historical Comparison
GEVO
ABSI

About GEVO Gevo Inc.

Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Share on Social Networks: